FDA Inspection 1180964 — Versiti Indiana Inc.
The FDA completed an inspection of Versiti Indiana Inc. on Sep 26, 2022 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 26, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbus, OH (United States)